Phase 2 clinical trial of dapansutrile for Parkinson’s confirmed

Cure Parkinson’s, in partnership with Van Andel Institute, is delighted to announce funding for a Phase 2 clinical of dapansutrile, an anti-inflammatory drug, to determine whether it can slow the progression of Parkinson’s.


Webinars Webinars

Webinar: Women with Parkinson’s – addressing sex and gender gaps in research

To mark International Women’s Day, Cure Parkinson’s is hosting a webinar on 5 March at 8:00 pm – do join us for what promises to be a lively and thought-provoking discussion.


Spring Research Update meeting 2024: watch again

Our Spring Research Update Meeting once again took place at the renowned Royal Society of Medicine, Wimpole Street, London where we invited guests to an inspiring agenda of some of the most up to date news of our funded research. Theme: the impact of the…


News Fundraising news

Cure Parkinson’s Fundraising Heroes: January 2024

It’s a great time of year to start thinking about trying something new, so get inspired by some of our 2023 fundraising heroes who came up with some brilliant and inventive ways to raise funds and awareness for our research. Community Fêtes In June, keen…


Press release

Press Release: Cure Parkinson’s welcomes Rory Cellan-Jones as new patron

7 February 2024 Cure Parkinson’s is delighted to announce that Rory Cellan-Jones, former technology correspondent for the BBC, writer, ‘Movers & Shakers’ podcaster, technology advisor and owner of one the UK’s most beloved rescue dogs, has joined Cure Parkinson’s as a patron. Rory was diagnosed…